Inflammatory bowel disease – one entity with many molecular faces

Sylwia Szymańska; Malgorzata Matuszczyk; Magdalena Osuch; Monika Meglicka; Edyta Szymanska; Joanna Bierła; Jaroslaw Kierkuś

doi:10.5114/pg.2019.90249

eISSN: 1897-4317
ISSN: 1895-5770

Gastroenterology Review/Przegląd Gastroenterologiczny

Current issue Archive Manuscripts accepted About the journal Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

Open access

4/2019
vol. 14

Send email

Copy url:

abstract:

Review paper

Inflammatory bowel disease – one entity with many molecular faces

Sylwia Szymańska

¹

,

Malgorzata Matuszczyk

²

,

Magdalena Osuch

³

,

Monika Meglicka

²

,

Edyta Szymanska

²

,

Joanna Bierła

¹

,

Jaroslaw Kierkuś

²

Department of Pathology, The Children’s Memorial Health Institute, Warsaw, Poland
Department of Gastroenterology, Hepatology, Feeding Disorders, and Paediatrics, The Children’s Memorial Health Institute, Warsaw, Poland
Medical Department, Bristol-Myers Squibb, Warsaw, Poland

Gastroenterology Rev 2019; 14 (4): 228–232

DOI: https://doi.org/10.5114/pg.2019.90249

Online publish date: 2019/12/20

View full text Get citation

PlumX metrics:

Inflammatory bowel disease (IBD) is a heterogenous group of chronic inflammations in the gastrointestinal tract, which traditionally consists of two types: Crohn’s disease and ulcerative colitis. They differ when it comes to clinical, endoscopic, and histopathological changes. The exact aetiology of IBD has not been fully comprehended, but what is known so far is that the aetiopathogenesis of the disease is compound. Many articles have been written on the cellular/molecular background of IBD. Based on various molecular pathways, new forms of the disease have been discovered, including very early-onset IBD (VEO-IBD) or IBD coexisting with primary sclerosing cholangitis. The aim of this article is to present the molecular mechanisms leading to IBD, focusing on new forms of this disorder.

keywords:

Inflammatory bowel disease – one entity with many molecular faces

Sylwia Szymańska 1 , Malgorzata Matuszczyk 2 , Magdalena Osuch 3 , Monika Meglicka 2 , Edyta Szymanska 2 , Joanna Bierła 1 , Jaroslaw Kierkuś 2

inflammatory bowel disease, Crohn’s disease, ulcerative colitis, genetics, molecular pathways

Sylwia Szymańska

¹

,

Malgorzata Matuszczyk

²

,

Magdalena Osuch

³

,

Monika Meglicka

²

,

Edyta Szymanska

²

,

Joanna Bierła

¹

,

Jaroslaw Kierkuś

²